Skip to main content

Table 2 The threshold dose prices at the 10th percentile of simulated epidemiological and economic values (over 500 simulations), using both 3.5% and 1.5% discount rates and an increased cost-effectiveness threshold of £30,000, compared to both halted vaccination and girls-only vaccination, with a £10 administration charge per dose

From: Assessing the cost-effectiveness of HPV vaccination strategies for adolescent girls and boys in the UK

Vaccination strategy £, versus halted vac. (3.5%) £, versus girls’ vac. (3.5%) £, versus halted vac. (1.5%) £, versus girls’ vac. (1.5%)
Girls, bivalent 68.07 - 1024.71 -
Girls, quadrivalent 140.85 - 1121.74 -
Girls, nonavalent 147.90 - 1232.70 -
Girls and boys, bivalent 32.13 –6.38 577.45 45.06
Girls and boys, quadrivalent 74.95 -4.84 654.07 67.12
Girls and boys, nonavalent 81.12 -6.04 676.54 49.89